Skip to Content

Eli Lilly Just Lost the Latest Round in its Patent Battle

February 12, 2016

U.S. Multinationals in Puerto RicoU.S. Multinationals in Puerto Rico

Eli Lilly (LLY) said on Friday it lost the latest round of a lengthy patent saga over its blockbuster Alimta lung cancer drug in the UK High Court, in a boost for generic drugmaker Actavis, now renamed Allergan .